# SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

> **NCT00917163** · PHASE4 · TERMINATED · sponsor: **Sahajanand Medical Technologies Limited** · enrollment: 13 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Supralimus(R) Sirolimus-Eluting Coronary Stent System
- **DEVICE:** Xience V™ Everolimus Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00917163
- **Lead sponsor:** Sahajanand Medical Technologies Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** due to unavoidable circumstances relating to logistic issues and regulatory processes in various countries causing unacceptable delays.
- **Last updated:** 2012-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917163, "SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00917163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*